TMPRSS2-ERG Fusion Gene Expression in Prostate Tumor Cells and Its Clinical and Biological Significance in Prostate Cancer Progression
about
Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response elementAntibody-independent targeted quantification of TMPRSS2-ERG fusion protein products in prostate cancer.TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers.Genomic rearrangements define lineage relationships between adjacent lepidic and invasive components in lung adenocarcinoma.The C-terminal fragment of prostate-specific antigen, a 2331 Da peptide, as a new urinary pathognomonic biomarker candidate for diagnosing prostate cancer.Identification of independent primary tumors and intrapulmonary metastases using DNA rearrangements in non-small-cell lung cancer.Fusion transcript loci share many genomic features with non-fusion loci.Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients.Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men.Predicting Prostate Biopsy Results Using a Panel of Plasma and Urine Biomarkers Combined in a Scoring System.Somatic Mutations in Prostate Cancer: Closer to Personalized Medicine.miRNAs as drivers of TMPRSS2-ERG negative prostate tumors in African American men.Significance of the TMPRSS2:ERG gene fusion in prostate cancer.A molecular signature of PCA3 and ERG exosomal RNA from non-DRE urine is predictive of initial prostate biopsy result.ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer.Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer.Loss of FOXO1 Cooperates with TMPRSS2-ERG Overexpression to Promote Prostate Tumorigenesis and Cell Invasion.
P2860
Q33640983-CD1DF6DE-3155-4F26-8BC5-354FCCFA7506Q33663401-D1F5CDD2-F2EF-4F64-84AF-8B4C742505EDQ34283031-56C78F22-0B55-4F6E-849D-77EDD6265A6DQ35088099-0ECFD4CF-61CB-49CA-A832-E4784244833BQ35176964-557B10AC-17DE-45B6-A5E5-102D7CEFD957Q35261674-DCF0F909-F987-443B-8730-BC16E9623C67Q35408969-40090983-7F55-4932-A31A-D7307E8E38D2Q35857757-FE67B132-ADFB-4B0E-8990-6B799DA22F33Q35956586-CC3E6C72-1870-4CDA-B4CB-AAC96E9C733DQ37139054-AD644B94-5007-4D2B-8442-A43363FC637BQ38325768-9B400C4F-0A77-47E2-B32E-AD08F3C7B87FQ39044222-6B627357-E0CC-4306-9436-18036CAA9F29Q39214638-D3736B7E-40C3-4CD7-8D6D-17568716C0EDQ40067022-F9DC3362-2E13-47D2-97A3-D4B8D3ACBB0BQ40311168-FDAD6840-BCE1-4145-8DD3-1E794D0E190CQ41988183-F503D796-AD27-476D-9DCC-2825FA7E2DACQ42335698-A16788B0-AAEB-43EF-9064-6D2A0D98EB88Q47685003-1515015D-901A-4974-913E-4771D76ED8FB
P2860
TMPRSS2-ERG Fusion Gene Expression in Prostate Tumor Cells and Its Clinical and Biological Significance in Prostate Cancer Progression
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
TMPRSS2-ERG Fusion Gene Expres ...... in Prostate Cancer Progression
@en
type
label
TMPRSS2-ERG Fusion Gene Expres ...... in Prostate Cancer Progression
@en
prefLabel
TMPRSS2-ERG Fusion Gene Expres ...... in Prostate Cancer Progression
@en
P2093
P2860
P1476
TMPRSS2-ERG Fusion Gene Expres ...... n Prostate Cancer Progression.
@en
P2093
Jason St John
Katelyn Powell
Sreenivasa R Chinni
P2860
P304
P356
10.4172/1948-5956.1000119
P577
2012-04-01T00:00:00Z